ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 85 filers reported holding ALLOVIR INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,598,344 | +118.9% | 743,416 | +246.2% | 0.00% | – |
| Q2 2023 | $730,082 | +268312.5% | 214,730 | +211.6% | 0.00% | – |
| Q1 2023 | $272 | +97.1% | 68,910 | +156.4% | 0.00% | – |
| Q4 2022 | $138 | -99.8% | 26,878 | +53.3% | 0.00% | – |
| Q2 2022 | $68,000 | -93.0% | 17,528 | -87.7% | 0.00% | -100.0% |
| Q1 2022 | $965,000 | +7.1% | 143,000 | +105.5% | 0.00% | – |
| Q4 2021 | $901,000 | -47.6% | 69,599 | -20.2% | 0.00% | -100.0% |
| Q2 2021 | $1,721,000 | – | 87,195 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $44,004,000 | 1.88% |
| GMT CAPITAL CORP | 2,758,846 | $21,767,000 | 1.35% |
| Regency Capital Management Inc.\DE | 75,010 | $592,000 | 0.73% |
| Redmile Group, LLC | 1,907,969 | $15,054,000 | 0.58% |
| Samsara BioCapital, LLC | 82,336 | $650,000 | 0.15% |
| Alkeon Capital Management | 4,923,104 | $38,843,000 | 0.13% |
| Woodline Partners LP | 1,087,093 | $8,577,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,625 | $612,000 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 44,987 | $355,000 | 0.07% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,143,634 | $9,023,000 | 0.07% |